Acid-Specific Formaldehyde Donor Is a Potential, Dual Targeting Cancer Chemotherapeutic/Chemo Preventive Drug for FANC/BRCA-mutant Cancer

Genes and Environment - United Kingdom
doi 10.1186/s41021-019-0136-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cancer Therapeutic Targeting Using Mutant–p53-Specific siRNAs

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Ellagic Acid as a Potential Anti-Cancer Drug

International Journal of Radiology & Radiation Therapy
2017English

Targeting Tankyrase 1 as a Therapeutic Strategy for BRCA-associated Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Investigational Drug Combined With Chemotherapy Improves Response in Patients With BRCA -Mutant Breast Cancer

Cancer
Cancer ResearchOncology
2017English

In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts

Angewandte Chemie - International Edition
CatalysisChemistry
2017English

In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts

Angewandte Chemie
2017English

Targeting Mutant AKT in Cancer

Cancer Discovery
Oncology
2015English

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Frontiers in Oncology
Cancer ResearchOncology
2018English

Phycocyanin: A Potential Drug for Cancer Treatment

Journal of Cancer
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy